Advertisement

Topics

IQVIA Response to FDA Statement

14:57 EDT 16 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
IQVIA™ (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. We also provide a select set of services to the FDA and other gov...

Other Sources for this Article

IQVIA Media Relations
Tor Constantino, +1-484-567-6732
tor.constantino@iqvia.com
or
IQVIA Investor Relations
Andrew Markwick, +1-973-257-7144
andrew.markwick@iqvia.com

NEXT ARTICLE

More From BioPortfolio on "IQVIA Response to FDA Statement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...